Impact of intrapartum antibiotics on the developing microbiota: a review

Abstract

The perinatal period sets the basis for the later physiological and immune homeostasis of the individual, with the intestinal microbiota being an important contributor to driving this homeostasis development. Therefore, the initial establishment and later development of the microbiota during early life may play a key role in later health. This early establishment of the intestinal microbiota is known to be affected by several factors, with gestational age, delivery mode, and feeding habits being extensively studied ones. Other factors are not so well understood, although knowledge has been accumulating in the last years. Among them, a factor of great relevance is the effect of perinatal exposure to antibiotics. Administration of intrapartum antimicrobial prophylaxis (IAP) to women during the delivery process represents the most common form of exposure to antibiotics during the perinatal period, present in around 30% of deliveries. During the last decade, evidence has accumulated demonstrating that IAP alters intestinal microbiota development in neonates. Moreover, recent evidence indicates that this practice may also be altering the infant intestinal resistome by increasing the levels of some antibiotic resistance genes. This evidence, as reviewed in this manuscript, suggests the interest in promoting the rational use of IAP. This practice has significantly reduced the risk of neonatal infections, but now the accumulating knowledge suggests the need for strategies to minimize its impact on the neonatal microbiota establishment.

Keywords

Neonate / microbiota / intrapartum / antibiotics / infant

References

[1] Sommer F.The gut microbiota - masters of host development and physiology.Nat Rev Microbiol2013;11:227-38

[2] Rautava S,Ouwehand A,Isolauri E.The hygiene hypothesis of atopic disease - an extended version.J Pediatr Gastroenterol Nutr2004;38:378-88

[3] Milani C,Bottacini F.The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota.Microbiol Mol Biol Rev2017;81:e00036-17 PMCID:PMC5706746

[4] Arrieta MC,Amenyogbe N,Finlay B.The intestinal microbiome in early life: health and disease.Front Immunol2014;5:427 PMCID:PMC4155789

[5] Bäckhed F,Peng Y.Dynamics and stabilization of the human gut microbiome during the first year of life.Cell Host Microbe2015;17:690-703

[6] Van Dyke MK,Lynfield R.Evaluation of universal antenatal screening for group B Streptococcus.N Engl J Med2009;360:2626-36

[7] Chai G,McMahon AW,Staffa J.Trends of outpatient prescription drug utilization in US children, 2002-2010.Pediatrics2012;130:23-31

[8] Di Renzo GC,Berardi A.Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference.J Matern Fetal Neonatal Med2015;28:766-82

[9] Verani JR,Schrag SJ.Division of Bacterial Diseases; National Center for Immunization and Respiratory Diseases; Centers for Disease Control and PreventionPrevention of perinatal group B Streptococcal disease - revised guidelines from CDC, 2010.MMWR Recomm Rep2010;59:1-36

[10] Smaill FM.Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.Cochrane Database Syst Rev2014;2014:CD007482 PMCID:PMC8078551

[11] Eley VA,Ryan R.Prophylactic cefazolin dosing in women with body mass index > 35 kg·m^-2 undergoing cesarean delivery: a pharmacokinetic study of plasma and interstitial fluid.Anesth Analg2020;131:199-207

[12] Ianiro G,Gasbarrini A.Antibiotics as deep modulators of gut microbiota: between good and evil.Gut2016;65:1906-15

[13] Jauréguy F,Panel P,Butel MJ.Effects of intrapartum penicillin prophylaxis on intestinal bacterial colonization in infants.J Clin Microbiol2004;42:5184-8 PMCID:PMC525278

[14] Aloisio I,Corvaglia LT.Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains.Appl Microbiol Biotechnol2014;98:6051-60

[15] Arboleya S,Milani C.Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics.J Pediatr2015;166:538-44

[16] Arboleya S,Solís G.Impact of prematurity and perinatal antibiotics on the developing intestinal microbiota: a functional inference study.Int J Mol Sci2016;17:649 PMCID:PMC4881475

[17] Zhou P,Liu B.Perinatal antibiotic exposure affects the transmission between maternal and neonatal microbiota and is associated with early-onset sepsis.mSphere2020;5:e00984-19 PMCID:PMC7031618

[18] Azad MB,Persaud RR.CHILD Study InvestigatorsImpact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study.BJOG2016;123:983-93

[19] Nogacka A,Suárez M.Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates.Microbiome2017;5:93 PMCID:PMC5549288

[20] Tapiainen T,Brinkac L.Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants.Sci Rep2019;9:10635 PMCID:PMC6650395

[21] Stearns JC,Gunn E.Intrapartum antibiotics for GBS prophylaxis alter colonization patterns in the early infant gut microbiome of low risk infants.Sci Rep2017;7:16527 PMCID:PMC5705725

[22] Imoto N,Aoyagi Y.Administration of β-lactam antibiotics and delivery method correlate with intestinal abundances of Bifidobacteria and Bacteroides in early infancy, in Japan.Sci Rep2021;11:6231 PMCID:PMC7973812

[23] Ainonen S,Mahmud MR.Antibiotics at birth and later antibiotic courses: effects on gut microbiota.Pediatr Res2022;91:154-62 PMCID:PMC8770115

[24] Coker MO,Dade E.Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study.BJOG2020;127:217-27 PMCID:PMC6803026

[25] Mazzola G,Ross RP.Early gut microbiota perturbations following intrapartum antibiotic prophylaxis to prevent group B Streptococcal disease.PLoS One2016;11:e0157527 PMCID:PMC4917232

[26] Chen YY,Moeder W.Impact of maternal intrapartum antibiotics, and caesarean section with and without labour on Bifidobacterium and other infant gut microbiota.Microorganisms2021;9:1847 PMCID:PMC8467529

[27] Kamal SS,Krych Ł.Impact of early exposure to cefuroxime on the composition of the gut microbiota in infants following cesarean delivery.J Pediatr2019;210:99-105.e2

[28] Dierikx T,Eck A.Influence of timing of maternal antibiotic administration during caesarean section on infant microbial colonisation: a randomised controlled trial.Gut2021;

[29] Corvaglia L,Martini S.Influence of intrapartum antibiotic prophylaxis for group B Streptococcus on gut microbiota in the first month of life.J Pediatr Gastroenterol Nutr2016;62:304-8

[30] Saturio S,Mancabelli L.Effect of intrapartum antibiotics prophylaxis on the bifidobacterial establishment within the neonatal gut.Microorganisms2021;9:1867 PMCID:PMC8471514

[31] Kenyon S,Jones D.Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial.The Lancet2008;372:1319-27

[32] Metz TD,Allshouse AA,Carey JC.Exposure to group B Streptococcal antibiotic prophylaxis and early childhood body mass index in a vaginal birth cohort.J Matern Fetal Neonatal Med2020;33:3318-23 PMCID:PMC6957762

[33] Gomez-Arango LF,McIntyre HD,Morrison M.Antibiotic treatment at delivery shapes the initial oral microbiome in neonates.Sci Rep2017;7:43481 PMCID:PMC5378909

[34] Li M,Ma J,Shi J.Comparing prophylactic use of cefazolin for SSI in cesarean section: a systematic review and meta-analysis.Arch Gynecol Obstet2021;303:313-20

[35] Lebeaux RM,Dade EF.The infant gut resistome is associated with E. coli and early-life exposures.BMC Microbiol2021;21:201 PMCID:PMC8252198

[36] Li W,Brinkac L.Vertical transmission of gut microbiome and antimicrobial resistance genes in infants exposed to antibiotics at birth.J Infect Dis2021;224:1236-46 PMCID:PMC8514186

[37] Glasgow TS,Wallin J.Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants.Pediatrics2005;116:696-702

[38] Ashkenazi-Hoffnung L,Ben-Haroush A,Amir J.The association of intrapartum antibiotic exposure with the incidence and antibiotic resistance of infantile late-onset serious bacterial infections.Clin Pediatr (Phila)2011;50:827-33

[39] Pärnänen K,Hultman J.Maternal gut and breast milk microbiota affect infant gut antibiotic resistome and mobile genetic elements.Nat Commun2018;9:3891 PMCID:PMC6155145

[40] Bojang A,Camara B.Impact of intrapartum oral azithromycin on the acquired macrolide resistome of infants' nasopharynx: a randomized controlled trial.Clin Infect Dis2020;71:3222-5 PMCID:PMC7819521